SCP Plus for Alzheimer Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Alzheimer Disease+3 More
SCP Plus - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new psychoeducational intervention (The Senior Companion Program Plus, or SCP Plus) to help African American caregivers of people with Alzheimer's disease or related dementia. The intervention will be delivered by senior companions who are trained to provide the intervention in the homes of caregivers. The goal is to reduce caregiver burden and stress, and improve coping skills and satisfaction with support social.

Eligible Conditions
  • Alzheimer Disease
  • Family
  • Alzheimer's Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: pre, post, 6-month follow up

pre, post, 6-month follow up
Change in caregiver burden and stress
Change in caregiver coping skills
Change in caregiver level of satisfaction with social support

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Services as usual
1 of 2
SCP Plus
1 of 2
Active Control
Experimental Treatment

20 Total Participants · 2 Treatment Groups

Primary Treatment: SCP Plus · No Placebo Group · N/A

SCP Plus
Behavioral
Experimental Group · 1 Intervention: SCP Plus · Intervention Types: Behavioral
Services as usualNoIntervention Group · 1 Intervention: Services as usual · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: pre, post, 6-month follow up

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,380 Previous Clinical Trials
3,446,736 Total Patients Enrolled
310 Trials studying Alzheimer Disease
865,431 Patients Enrolled for Alzheimer Disease
The University of Texas at ArlingtonLead Sponsor
25 Previous Clinical Trials
2,393 Total Patients Enrolled
1 Trials studying Alzheimer Disease
171 Patients Enrolled for Alzheimer Disease

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
A Senior Companion is someone who is currently participating in the Senior Companions Program and is providing respite services to the caregivers
The participants in the study must be able to provide written informed consent, be willing to be randomized into a group, attend all study related visits, and comply with the study protocol.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 18th, 2021

Last Reviewed: October 25th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.